Table 2 Detailed information on patients with primary breast lymphomas. Abbreviations: DLBCL: diffuse large B-cell.
From: Clinical and pathological features of lymphomas in the breast: a comprehensive multicentric study
Age at diagnosis | Range 18–96 years (mean 68.4) | |
|---|---|---|
Presentations | Palpation finding | 38 (88.4%) |
Asymptomatic, discovered at control visit | 3 (7.0%) | |
No information | 2 (4.7%) | |
Radiology findings | BIRADS 5 (sonography) | 2 (4.7%) |
BIRADS 4 (sonography) | 8 (18.6%) | |
BIRADS 4a (mammography) | 1 (2.3%) | |
Not conclusive (sonography) | 1 (2.3%) | |
Incidental findings at CT | 1 (2.3%) | |
MRI suspicious for breast carcinoma | 1 (2.3%) | |
No information | 29 (67.4%) | |
Histology | DLBCL NOS | 30 (69.8%) |
EMZL | 8 (18.6%) | |
Follicular lymphoma | 3 (7.0%) | |
Mantle cell lymphoma | 1 (2.3%) | |
Lymphoplasmacytic lymphoma | 1 (2.3%) | |
Stage at diagnosis | I | 1 (2.3%) |
II | 4 (9.3%) | |
III | 1 (2.3%) | |
IV | 4 (9.3%) | |
No information | 33 (76.7%) | |
